1
项与 Allogeneic T cell therapy(Smart Immune SAS) 相关的临床试验A Phase I/II Study Evaluating the Safety and the Efficacy of SMART101 Injection to Accelerate Immune Reconstitution After T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric and Adult Patients With Hematological Malignancies
The purpose of this study is to evaluate the safety and the efficacy of SMART101 (Human T Lymphoid Progenitor (HTLP)) injection to accelerate immune reconstitution after T cell depleted allogeneic hematopoietic stem cell transplantation (HSCT) in adult and pediatric patients with hematological malignancies.
100 项与 Allogeneic T cell therapy(Smart Immune SAS) 相关的临床结果
100 项与 Allogeneic T cell therapy(Smart Immune SAS) 相关的转化医学
100 项与 Allogeneic T cell therapy(Smart Immune SAS) 相关的专利(医药)
100 项与 Allogeneic T cell therapy(Smart Immune SAS) 相关的药物交易